Search Results - "Spire, B."

Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study by Molina, Jean-Michel, Charreau, Isabelle, Spire, Bruno, Cotte, Laurent, Chas, Julie, Capitant, Catherine, Tremblay, Cecile, Rojas-Castro, Daniela, Cua, Eric, Pasquet, Armelle, Bernaud, Camille, Pintado, Claire, Delaugerre, Constance, Sagaon-Teyssier, Luis, Mestre, Soizic Le, Chidiac, Christian, Pialoux, Gilles, Ponscarme, Diane, Fonsart, Julien, Thompson, David, Wainberg, Mark A, Doré, Veronique, Meyer, Laurence, Meyer, L, Capitant, C, Charreau, I, Netzer, E, Leturque, N, Binesse, J, Foubert, V, Saouzanet, M, Euphrasie, F, Carette, D, Guillon, B, Saïdi, Y, Aboulker, J P, Spire, B, Suzan, M, Cattin, G, Demoulin, B, Sagaon-Teyssier, L, Lorente, N, Doré, V, Choucair, E, Le Mestre, S, Mennecier, A, Etien, N, Simon, M C, Diallo, A, Gibowski, S, Delfraissy, J F, Thompson, D, Sas, J, Pankovitch, J, Klein, M, Anis, A, Molina, Jean-Michel, Wainberg, Mark A, Trottier, Benoit, Tremblay, Cécile, Baril, Jean-Guy, Pialoux, Gilles, Cotte, Laurent, Chéret, Antoine, Pasquet, Armelle, Cua, Eric, Besnier, Michel, Rozenbaum, Willy, Chidiac, Christian, Delaugerre, Constance, Bajos, Nathalie, Timsit, Julie, Peytavin, Gilles, Fonsart, Julien, Durand-Zaleski, Isabelle, Meyer, Laurence, Aboulker, Jean-Pierre, Spire, Bruno, Suzan-Monti, Marie, Girard, Gabriel, Castro, Daniela Rojas, Préau, Marie, Morin, Michel, Thompson, David, Capitant, Catherine, Mennecier, Anaïs, Choucair, Elias, Doré, Véronique, Simon, Marie-Christine, Charreau, Isabelle, Otis, Joanne, Lert, France, Diallo, Alpha, Gibowski, Séverine, Rabian, Cecile

“…Data for on-demand pre-exposure prophylaxis (PrEP) are scarce. We implemented a cohort study to assess its efficacy, safety, and effect on sexual behaviour. We…”
Get full text

Dolutegravir-based and low-dose efavirenz-based regimen for the initial treatment of HIV-1 infection (NAMSAL): week 96 results from a two-group, multicentre, randomised, open label, phase 3 non-inferiority trial in Cameroon by Calmy, Alexandra, Tovar Sanchez, Tamara, Kouanfack, Charles, Mpoudi-Etame, Mireille, Leroy, Sandrine, Perrineau, Ségolène, Lantche Wandji, Martial, Tetsa Tata, Darius, Omgba Bassega, Pierette, Abong Bwenda, Thérèse, Varloteaux, Marie, Tongo, Marcel, Mpoudi-Ngolé, Eitel, Montoyo, Alice, Mercier, Noémie, LeMoing, Vincent, Peeters, Martine, Reynes, Jacques, Delaporte, Eric, Calmy, A, Tovar Sanchez, T, Kouanfack, C, Mpoudi-Etame, M, Leroy, S, Perrineau, S, Lantche-Wandji, M, Tetsa-Tata, D, Omgba-Bassega, P, Abong-Bwenda, T, Varloteaux, M, Tongo, M, Mpoudi-Ngolé, E, Montoyo, A, Mercier, N, LeMoing, V, Peeters, M, Reynes, J, Delaporte, E, Ayouba, A, Agholeng, A, Butel, C, Cournil, A, Eymard-Duvernay, S, Granouillac, B, Izard, S, Lacroix, A, Serrano, L, Vidal, N, Fouda, PJ, Mougnoutou, R, Olinga, J, Omgba, V, Tchokonte-Ngandé, SC, Ymele, B, Epoupa-Mpacko, CD, Fotso, M, Moukoko, R, Nké, T, Akamba, A, Lekelem, S, Tongo-Fotack, SB, Ngono, S, Tanga, M, Ebong, E, Edoul-Mbesse, G, Ciaffi, L, Koulla-Shiro, S, Manirakiza, G, Mimbé, ED, Boyer, S, Bousmah, M, Maradan, G, Nishimwe, ML, Spire, B, Lê, MP, Peytavin, G, Diallo, A, Fournier, I, Rekacewicz, C, Perez Casas, C

“…BACKGROUNDUpdated WHO guidelines recommend a dolutegravir-based regimen as the preferred first-line treatment for HIV infection and low-dose efavirenz (400 mg)…”
Get full text

Lessons learned from the experiences of informal PrEP users in France: results from the ANRS-PrEPage study by Rivierez, I., Quatremere, G., Spire, B., Ghosn, J., Rojas Castro, D.

“…Before January 2016, Pre-Exposure Prophylaxis (PrEP), a new biomedical HIV-prevention tool, was only available in France via ANRS-Ipergay clinical study but…”
Get full text

Benefits and challenges of a community-based programme for women living with HIV in Mali by Perray, M., Traore, D., Riegel, L., Rojas Castro, D., Spire, B., Mora, M., Yattassaye, A., Préau, M.

“…Gundo-So is a community-based programme developed by and for women living with HIV (WLHIV) in Mali through the ARCAD-Santé-PLUS association. It provides…”
Get full text

How PrEP users constitute a community in the MSM population through their specific experience and management of stigmatization. The example of the French ANRS-PREVENIR study by Puppo, C., Spire, B., Morel, S., Génin, M., Béniguel, L., Costagliola, D., Ghosn, J., Mabire, X., Molina, J. M., Rojas Castro, D., Préau, M.

“…The ANRS-PREVENIR (2017-2020) prospective cohort study aims to reduce the number of new HIV infections in the "Ile-de-France" region in France, by enrolling…”
Get full text

Increased mortality in HIV/HCV-coinfected compared to HCV-monoinfected patients in the DAA era due to non-liver-related death by Chalouni, Mathieu, Pol, Stanislas, Sogni, Philippe, Fontaine, Hélène, Lacombe, Karine, Marc-Lacombe, Jean, Esterle, Laure, Dorival, Celine, Bourlière, Marc, Bani-Sadr, Firouzé, de Ledinghen, Victor, Zucman, David, Larrey, Dominique, Salmon, Dominique, Carrat, Fabrice, Wittkop, Linda, Salmon, D., Wittkop, L., Sogni, P., Esterle, L., Trimoulet, P., Izopet, J., Serfaty, L., Paradis, V., Spire, B., Carrieri, P., Valantin, M.A., Pialoux, G., Chas, J., Poizot-Martin, I., Barange, K., Naqvi, A., Rosenthal, E., Bicart-See, A., Bouchaud, O., Gervais, A., Lascoux-Combe, C., Goujard, C., Lacombe, K., Duvivier, C., Neau, D., Morlat, P., Bani-Sadr, F., Meyer, L., Boufassa, F., Autran, B., Roque, A.M., Solas, C., Fontaine, H., Costagliola, D., Piroth, L., Simon, A., Zucman, D., Boué, F., Miailhes, P., Billaud, E., Aumaitre, H., Rey, D., Peytavin, G., Petrov-Sanchez, V., Lebrasseur-Longuet, D.

“…Direct-acting antivirals (DAA) lead to high sustained virological response (SVR) rates and decrease the risk of disease progression. We compared SVR rates and…”
Get full text

A Randomized Controlled Trial to Study the Transmission of SARS-CoV-2 and Other Respiratory Viruses During Indoor Clubbing Events (ANRS0066s ITOC Study) by Luong Nguyen, Liem Binh, Goupil de Bouillé, Jeanne, Menant, Lola, Noret, Marion, Dumas, Audrey, Salmona, Maud, Le Goff, Jérôme, Delaugerre, Constance, Crépey, Pascal, Zeggagh, Jeremy

“…Abstract Background In the context of the circulation of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) B.1.617.2 (Delta) variant,…”
Get full text

Perception of PrEP‐related stigma in PrEP users: Results from the ANRS‐PREVENIR cohort by Protiere, C., Sagaon‐Teyssier, L., Donadille, C., Sow, A., Gaubert, G., Girard, G., Mora, M., Assoumou, L., Beniguel, L., Michels, D., Ghosn, J., Costagliola, D., Rojas Castro, D., Molina, J.‐M., Spire, B.

“…Introduction Since the advent of HIV pre‐exposure prophylaxis (PrEP), stigma has been shown to be a major barrier to its uptake and adherence. It is therefore…”
Get full text

Women living with HIV still lack highly effective contraception: results from the ANRS VESPA2 study, France, 2011 by Maraux, B, Hamelin, C, Bajos, N, Dray-Spira, R, Spire, B, Lert, F

“…Abstract Objectives Advances in antiretroviral treatment (ART) have led to improvements in reproductive health for women living with HIV. This paper aims to…”
Get full text

HCV-Related Mortality Among HIV/HCV Co-infected Patients: The Importance of Behaviors in the HCV Cure Era (ANRS CO13 HEPAVIH Cohort) by Santos, Melina Erica, Protopopescu, Camelia, Sogni, Philippe, Yaya, Issifou, Piroth, Lionel, Bailly, François, Marcellin, Fabienne, Esterle, Laure, Wittkop, Linda, Rosenthal, Eric, Morlat, Philippe, Roux, Perrine, de Araujo, Wildo Navegantes, Salmon-Ceron, Dominique, Carrieri, Maria Patrizia

“…Mortality among individuals co-infected with HIV and hepatitis C virus (HCV) is relatively high. We evaluated the association between psychoactive substance…”
Get full text

Daily cannabis and reduced risk of steatosis in human immunodeficiency virus and hepatitis C virus‐co‐infected patients (ANRS CO13‐HEPAVIH) by Vilotitch, A., Esterle, L., Spire, B., Rey, D., Carrieri, P., Salmon, D, Trimoulet, P, Izopet, J, Poizot‐Martin, I, Barange, K, Naqvi, A, Rosenthal, E, Bouchaud, O, Goujard, C, Lacombe, K, Dominguez, S, Autran, B, Roque, A.M., Boué, F, Aumaître, H, Salmon, D, Katlama, C, Stitou, H, Charlotte, F, Fourati, S, Simon, A, Cacoub, P, Pialoux, G, Bendjaballah, F, Le Pendeven, C, Marchou, B, Selves, J, Uzan, M, Ferro‐Collados, M.J, Gervais, A, Adle‐Biassette, H, Molina, J.M, Duclos, J, Palmer, P, Girard, P.M, Viala, C, Goujard, C, Pallier, C, Lortholary, O, Duvivier, C, Mélard, A, Neau, D, Cazanave, C, Dupon, M, Reigadas, S, Lacoste, D, Roger‐Schmeltz, J, Carmen Pertusa, M, Vandenhende, M, Caldato, S, Lazzaro, E, Greib, C, Bioulac‐Sage, P, Majerholc, C, Boué, F, Kansau, I, Chambrin, V, Pignon, C, Fior, R, Martinez, V, Dominguez, S, Lelièvre, J.D, Lascaux, A.S, Raffi, F, Ader, F, Biron, F, Boibieux, A, Koffi, J, Lack, P, Maynard, M, Amiri, M, Piroth, L, Chavanet, P, Waldner‐Combernoux, A, Croisier‐Bertin, D, Rouger, C, Beniken, D, Ritleng, A.‐S, Payssan, V, Breau, S, Raho‐Moussa, M, Ogoudjobi, S, Azar, M, Chesnel, C, Maradan, G, Kurkdji, P, Kmiec, I, Pietri, M.P, Guet, P, Mebarki, M, Delaune, J, Gillet, S, Jacquet, A, Protopopescu, C, Rosellini, S

“…Summary Liver steatosis is common in human immunodeficiency virus (HIV)‐hepatitis C virus (HCV)‐co‐infected patients. Some recent studies have found that…”
Get full text

Prognostic factors of survival in HIV/HCV co‐infected patients with hepatocellular carcinoma: The CARCINOVIC Cohort by Gelu‐Simeon, Moana, Lewin, Maïté, Ostos, Maria, Bayan, Tatiana, Beso Delgado, Maria, Teicher, Elina, Layese, Richard, Roudot‐Thoraval, Françoise, Fontaine, Hélène, Sobesky, Rodolphe, Salmon‐Céron, Dominique, Samuel, Didier, Seror, Olivier, Nahon, Pierre, Meyer, Laurence, Duclos‐Vallée, Jean‐Charles, Petrov‐Sanchez, Ventzislava, Autran, Brigitte, Boufassa, Faroudy, Bourlière, Marc, Dominguez, Stéphanie, Hézode, Christophe, Pageaux, Georges‐Philippe, Poizot‐Martin, Isabelle, Roque‐Afonso, Anne‐Marie, Samri, Assia, Vittecoq, Daniel, Dabis, F, Winnock, M, Loko, A, Sogni, P, Benhamou, Y, Trimoulet, P, Izopet, J, Paradis, V, Spire, B, Carrieri, P, Katlama, C, Pialoux, G, Valantin, A, Bonnard, P, Poizot‐Martin, I, Marchou, B, Rosenthal, E, Garipuy, D, Bouchaud, O, Gervais, A, Lascoux‐Combe, C, Goujard, C, Lacombe, K, Duvivier, C, Vittecoq, D, Neau, D, Morlat, P, BaniSadr, F, Boufassa, F, Dominguez, S, Autran, B, Roque, M, Solas, C, Serfaty, L, Chêne, G, Costagliola, D, Zucman, D, Simon, A, Dominguez, S, Billaud, E, Miailhes, P, Devoto, J, Couffin‐Cadiergues, S, Nahon, P, Mahuas‐Bourcier, V, Zucman‐Rossi, J, Bedossa, P, Laurent, A, Layese, R, Durand‐Zaleski, I, Marche, P, Thibault, V, Guyader, D, Dharancy, S, Leroy, V, Vilgrain, V, Bonjour, M, Cagnot, C, Petrov‐Sanchez, V

“…Background & Aims HIV/HCV co‐infected patients with hepatocellular carcinoma (HCC) have poorer survival than HCV mono‐infected patients. We aimed to evaluate…”
Get full text

Importance of the patient‐physician interaction in assessing acceptability of HIV cure trials by Protière, C, Préau, M, Carrieri, P, Lambotte, O, Spire, B, Suzan‐Monti, M

Get full text

Changes in kidney function among men having sex with men starting on demand tenofovir disoproxil fumarate – emtricitabine for HIV pre‐exposure prophylaxis by Liegeon, Geoffroy, Antoni, Guillemette, Pialoux, Gilles, Capitant, Catherine, Cotte, Laurent, Charreau, Isabelle, Tremblay, Cécile, Cua, Eric, Senneville, Eric, Raffi, François, Meyer, Laurence, Molina, Jean‐Michel, Meyer, L, Capitant, C, Charreau, I, Netzer, E, Leturque, N, Binesse, J, Foubert, V, Saouzanet, M, Euphrasie, F, Carette, D, Guillon, B, Saïdi, Y, Aboulker, J P, Spire, B, Suzan, M, Cattin, G, Demoulin, B, Sagaon‐Teyssier, L, Lorente, N, Doré, V, Choucair, E, Le Mestre, S, Mennecier, A, Etien, N, Simon, M C, Diallo, A, Gibowski, S, Delfraissy, J F, Thompson, D, Sas, J, Pankovitch, J, Klein, M, Anis, A, Molina, Jean‐Michel, Wainberg, Mark A, Trottier, Benoit, Tremblay, Cécile, Baril, Jean‐Guy, Pialoux, Gilles, Cotte, Laurent, Chéret, Antoine, Pasquet, Armelle, Cua, Eric, Hall, Nolwenn, Rozenbaum, Willy, Chidiac, Christian, Delaugerre, Constance, Bajos, Nathalie, Timsit, Julie, Peytavin, Gilles, Fonsart, Julien, Durand‐Zaleski, Isabelle, Meyer, Laurence, Aboulker, Jean‐Pierre, Spire, Bruno, Suzan‐Monti, Marie, Girard, Gabriel, Castro, Daniela Rojas, Préau, Marie, Morin, Michel, Thompson, David, Capitant, Catherine, Mennecier, Anaïs, Choucair, Elias, Doré, Véronique, Simon, Marie‐Christine, Charreau, Isabelle, Otis, Joanne, Lert, France, Diallo, Alpha, Gibowski, Séverine, Rabian, Cecile

“…Introduction Daily pre‐exposure prophylaxis (PrEP) with tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) is associated with a small but statistically…”
Get full text

Informal pre‐exposure prophylaxis use in France: results from the Flash PrEP survey (2014) by Rojas Castro, D, Quatremere, G, Sagaon‐Teyssier, L, Le Gall, J‐M, Preau, M, Suzan‐Monti, M, Spire, B

Get full text

Heterosexual practices of women and men living with HIV attending hospital outpatient services (ANRS-VESPA2 survey): a French comparative study with the general population (CSF survey) by Boyer, V., Vilotitch, A., Panjo, H., Sagaon-Teyssier, L., Marcellin, F., Dray-Spira, R., Spire, B., Bajos, N.

“…HAART has improved the well-being of many people living with HIV (PLWH). This study aimed at (i) comparing heterosexual practices between PLWH and the general…”
Get full text

Cannabis Use and Reduced Risk of Insulin Resistance in HIV-HCV Infected Patients: A Longitudinal Analysis (ANRS CO13 HEPAVIH) by Carrieri, Maria Patrizia, Serfaty, Lawrence, Vilotitch, Antoine, Winnock, Maria, Poizot-Martin, Isabelle, Loko, Marc-Arthur, Lions, Caroline, Lascoux-Combe, Caroline, Roux, Perrine, Salmon-Ceron, Dominique, Spire, Bruno, Dabis, Francois

“…Background. Diabetes and insulin resistance (IR) is common in human immunodeficiency virus–hepatitis C virus (HIV–HCV)-coinfected patients, a population also…”
Get full text

Patterns of adherence to antiretroviral therapy and HIV drug resistance over time in the Stratall ANRS 12110/ESTHER trial in Cameroon by Meresse, M, March, L, Kouanfack, C, Bonono, R‐C, Boyer, S, Laborde‐Balen, G, Aghokeng, A, Suzan‐Monti, M, Delaporte, E, Spire, B, Carrieri, M‐P, Laurent, C

“…Objectives The emergence of HIV drug resistance is a crucial issue in Africa, where second‐line antiretroviral therapy (ART) is limited, expensive and complex…”
Get full text

Hepatitis B testing, treatment, and virologic suppression in HIV-infected patients in Cameroon (ANRS 12288 EVOLCAM) by Liégeois, Florian, Boyer, Sylvie, Eymard-Duvernay, Sabrina, Carrieri, Patrizia, Kouanfack, Charles, Domyeum, Jenny, Maradan, Gwenaëlle, Ducos, Jacques, Mpoudi-Ngolé, Eitel, Spire, Bruno, Delaporte, Eric, Kuaban, Christopher, Vidal, Laurent, Laurent, Christian

“…Hepatitis B is a major concern in Africa, especially in HIV-infected patients. Unfortunately, access to hepatitis B virus (HBV) testing and adequate treatment…”
Get full text

Adherence to HAART in French HIV-infected injecting drug users : The contribution of buprenorphine drug maintenance treatment by MOATTI, J. P, CARRIERI, M. P, SPIRE, B, GASTAUT, J. A, CASSUTO, J. P, MOREAU, J

“…Objectives: To assess adherence to highly active antiretroviral therapies (HAART) in a cohort of French patients infected by HIV through injection drug use…”
Get full text